Chemoinformaics analysis of DOCOSA-1,21-DIENE
| Molecular Weight | 306.578 | nRot | 19 |
| Heavy Atom Molecular Weight | 264.242 | nRig | 6 |
| Exact Molecular Weight | 306.329 | nRing | 0 |
| Solubility: LogS | -4.62 | nHRing | 0 |
| Solubility: LogP | 4.505 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 64.7453 |
| nHD | 0 | BPOL | 42.1347 |
| QED | 0.574 |
| Synth | 1.154 |
| Natural Product Likeliness | 0.031 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.004 |
| HIA | 0.002 |
| CACO-2 | -4.247 |
| MDCK | 0.0000161 |
| BBB | 0.842 |
| PPB | 0.957709 |
| VDSS | 1.864 |
| FU | 0.0275793 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.642 |
| CYP2c19-inh | 0.879 |
| CYP2c19-sub | 0.176 |
| CYP2c9-inh | 0.638 |
| CYP2c9-sub | 0.44 |
| CYP2d6-inh | 0.163 |
| CYP2d6-sub | 0.124 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.245 |
| CL | 8.316 |
| T12 | 0.438 |
| hERG | 0.095 |
| Ames | 0.01 |
| ROA | 0.049 |
| SkinSen | 0.803 |
| Carcinogencity | 0.212 |
| EI | 0.994 |
| Respiratory | 0.157 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.677075 |